rs587778004

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PVS1_ModeratePM2

The NM_000548.5(TSC2):​c.-30+1G>A variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000784 in 1,275,592 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.8e-7 ( 0 hom. )

Consequence

TSC2
NM_000548.5 splice_donor, intron

Scores

3
Splicing: ADA: 1.000
2

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 1.62

Publications

0 publications found
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
NTHL1 (HGNC:8028): (nth like DNA glycosylase 1) The protein encoded by this gene is a DNA N-glycosylase of the endonuclease III family. Like a similar protein in E. coli, the encoded protein has DNA glycosylase activity on DNA substrates containing oxidized pyrimidine residues and has apurinic/apyrimidinic lyase activity. [provided by RefSeq, Oct 2008]
NTHL1 Gene-Disease associations (from GenCC):
  • familial adenomatous polyposis 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Orphanet
  • NTHL1-deficiency tumor predisposition syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • breast cancer
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • meningioma
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000548.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.014933628 fraction of the gene. No cryptic splice site detected. Exon removal is inframe change.
PM2
Very rare variant in population databases, with high coverage;

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000548.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC2
NM_000548.5
MANE Select
c.-30+1G>A
splice_donor intron
N/ANP_000539.2P49815-1
TSC2
NM_001406663.1
c.-30+1G>A
splice_donor intron
N/ANP_001393592.1A0A2R8Y6C9
TSC2
NM_001114382.3
c.-30+1G>A
splice_donor intron
N/ANP_001107854.1P49815-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC2
ENST00000219476.9
TSL:5 MANE Select
c.-30+1G>A
splice_donor intron
N/AENSP00000219476.3P49815-1
TSC2
ENST00000350773.9
TSL:1
c.-30+1G>A
splice_donor intron
N/AENSP00000344383.4P49815-4
TSC2
ENST00000401874.7
TSL:1
c.-30+1G>A
splice_donor intron
N/AENSP00000384468.2P49815-5

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
7.84e-7
AC:
1
AN:
1275592
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
620434
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25440
American (AMR)
AF:
0.00
AC:
0
AN:
19214
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18440
East Asian (EAS)
AF:
0.0000313
AC:
1
AN:
31898
South Asian (SAS)
AF:
0.00
AC:
0
AN:
61854
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
32012
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4258
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1029644
Other (OTH)
AF:
0.00
AC:
0
AN:
52832
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Tuberous sclerosis 2 (1)
-
1
-
Tuberous sclerosis syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Pathogenic
31
DANN
Benign
0.84
PhyloP100
1.6
PromoterAI
-0.55
Under-expression
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.81
SpliceAI score (max)
0.96
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.96
Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs587778004;
hg19: chr16-2098067;
COSMIC: COSV99526611;
COSMIC: COSV99526611;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.